A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Clinical trial NCT06955728 · RECRUITING

Trial details

NCT number: NCT06955728
Sponsor: University of Witwatersrand, South Africa
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

RSV Infections RSV Immunisation Preterm Labour

Start date: 2025-09-03
Primary completion: 2028-02-29
Enrollment: 13000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.